Systemic Therapy in Patients with Resectable and Unresectable Cases of Giant Cell Tumor: A Systematic Review

ISSN Print: 2151-1934
ISSN Online: 2151-1942
www.scirp.net/journal/jct
E-mail: [email protected]

Citations

"Systemic Therapy in Patients with Resectable and Unresectable Cases of Giant Cell Tumor: A Systematic Review"
written by Philip B. Kaiser, Jocelyn T. Compton, Jon-Michael E. Caldwell, Thomas R. Hickernell, Francis Y. Lee,
published by Journal of Cancer Therapy, Vol.5 No.4, 2014

has been cited by the following article(s):

[1]	Metastatic giant cell tumour of bone: a narrative review of management options and approaches
	ANZ Journal of Surgery, 2022

[2]	Functional Outcome and Time Taken for Consolidation in Giant Cell Tumor after Fibular Strut Grafting Based on Intratumor Cavity Volume: A Retrospective and …
	2020

[3]	Treatment with denosumab in a recurrent giant cell tumor of cervical spine: A case report
	2019

[4]	Prognosis of metastatic giant cell tumor of bone in the pre-denosumab era. A systematic review and a meta-analysis
	Japanese Journal of Clinical Oncology, 2018

[5]	Role of Bisphosphonates as Adjuvants of Surgery in Giant Cell Tumor of Spine
	2018

[6]	Respuesta completa y prolongada al tratameinto con pamidronato en metástasis pulmonares de un tumor de células gigantes óseo
	2017

[7]	RESPUESTA COMPLETA Y PROLONGADA AL TRATAMIENTO CON PAMIDRONATO EN METÁSTASIS PULMONARES DE UN TUMOR DE CÉLULAS …
	2017

[8]	Respuesta completa y prolongada al tratamiento con pamidronato en metástasis pulmonares de un tumor de células gigantes óseo
	Oncología …, 2017

[1]	Metastatic giant cell tumour of bone: a narrative review of management options and approaches ANZ Journal of Surgery, 2022 DOI:10.1111/ans.17520

[2]	Prognosis of metastatic giant cell tumor of bone in the pre-denosumab era. A systematic review and a meta-analysis Japanese Journal of Clinical Oncology, 2018 DOI:10.1093/jjco/hyy067

[3]	Respuesta completa y prolongada al tratamiento con pamidronato en metástasis pulmonares de un tumor de células gigantes óseo Oncología Clínica, 2017 DOI:10.56969/oc.v22i2.71